R&D DNA as a programmable language, with Adrian Woolfson and Kai... A new technology just announced this weekend in a paper in Nature could have a radical impact on how gene assembly is carried out.
News Boundless Bio raises $100m for circular DNA cancer therapy Boundless Bio’s plans to develop a new class of cancer therapies targeting DNA found outside the nucleus of malignant cells have been boosted by a $100 million fundraising
R&D Inside out – the coming of age of organ-on-a-chip technology Perhaps the most beautiful thing about pharmacology, and the healthcare industry at large, is the continued pursuit of new ideas and innovations.
Events Partner Content Oligonucleotide Therapeutics and Delivery Conference Oligonucleotide Therapeutics and Delivery
News After setback, Rhythm gets good news on Imcivree from FDA Rhythm Pharma has secured the first approval in the US for a drug to treat hypothalamic obesity.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.